English

NEUROGENESIS INC

EDGAR

Filing (10QSB) · filed 2004-11-18

24 filing records in this dataset, filed from 2000-11-15 to 2004-11-18. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

604 thousand USD

2004-09-30 · USD

Exact inputs and evidence

Revenue: 603628 USD Source

Operating margin

-12.9%

2004-09-30 · %

Exact inputs and evidence

Operating Income: -77878 USD Source
Revenue: 603628 USD Source

Operating cash flow

-27.7 thousand USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -27705 USD Source

Free cash flow

-47.1 thousand USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -27705 USD Source
Capital Expenditure: 19420 USD Source

Cash and cash equivalents: 224 thousand USD 2004-09-30 Source
Exact value

223659 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2004-11-18.

Financial data available through: 2003-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2003-12-31
Operating income: 5 of 11 periods available· newest 2003-12-31
Net income: 5 of 11 periods available· newest 2003-12-31
Operating cash flow: 4 of 11 periods available· newest 2003-12-31
Capital expenditure: 3 of 11 periods available· newest 2003-12-31
Total assets: 3 of 11 periods available· newest 2002-12-31
Total liabilities: 1 of 11 periods available· newest 2000-12-31
Current assets: 2 of 11 periods available· newest 2000-12-31
Current liabilities: 3 of 11 periods available· newest 2002-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+69.8%

Prior period

USD 1.32 million

2002-01-01 – 2002-12-31
Current period

USD 2.25 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

2246470 − 1323392 = 923078 USD

1323392 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
2246470 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Year-over-year change in Revenue: 923078 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2246470 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000007.txt#947 Input fundies:Revenue: 1323392 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000007.txt#947
The citation records this snapshot. The page link may show a newer release later.
Net income
+287%

Prior period

USD 25,881

2002-01-01 – 2002-12-31
Current period

USD 100,151

2003-01-01 – 2003-12-31

Exact inputs and evidence

100151 − 25881 = 74270 USD

25881 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
100151 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Year-over-year change in Net income: 74270 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 100151 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000007.txt#962 Input fundies:NetIncome: 25881 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000007.txt#962
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-58.6%

Prior period

USD 171,259

2002-01-01 – 2002-12-31
Current period

USD 70,857

2003-01-01 – 2003-12-31

Exact inputs and evidence

70857 − 171259 = -100402 USD

171259 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
70857 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Year-over-year change in Operating cash flow: -100402 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 70857 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#312 Input fundies:OperatingCashFlow: 171259 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#312
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 2.25 million 100% of revenue
Operating costs Derived USD 2.13 million 95% of revenue
Operating income USD 113,298 5% of revenue
Tax, interest and other Derived USD 13,147 0.6% of revenue
Net income USD 100,151 4.5% of revenue

Cash

Operating cash flow USD 70,857 3.2% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived USD 70,857 3.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Operating loss: operating costs were 185% of revenue.
2000 Operating loss: operating costs were 111% of revenue.
2001 Operating loss: operating costs were 110% of revenue.
2002 Net income was higher than operating income, so the split is not drawn.
2003 95%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	276815	512353 Derived	-235538	13404 Derived	-248942	5802 Derived	Source 1999-01-01 – 1999-12-31: 276815 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -235538 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -248942 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 19433 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 13631 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	413030	458493 Derived	-45463	9393 Derived	-54856	8071 Derived	Source 2000-01-01 – 2000-12-31: 413030 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -45463 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -54856 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 11678 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 3607 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	548799	602889 Derived	-54090	-11498 Derived	-42592	Unavailable	Source 2001-01-01 – 2001-12-31: 548799 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -54090 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -42592 USD Inspect Net Income Open source
2002 2002-01-01 – 2002-12-31	1323392	1299587 Derived	23805	-2076 Derived	25881	Unavailable	Source 2002-01-01 – 2002-12-31: 1323392 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 23805 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 25881 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 171259 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	2246470	2133172 Derived	113298	13147 Derived	100151	70857 Derived	Source 2003-01-01 – 2003-12-31: 2246470 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 113298 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 100151 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 70857 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.2M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	276815	Revenue: 276815 Open source
20002000-12-31	Revenue	413030	Revenue: 413030 Open source
20012001-12-31	Revenue	548799	Revenue: 548799 Open source
20022002-12-31	Revenue	1323392	Revenue: 1323392 Open source
20032003-12-31	Revenue	2246470	Revenue: 2246470 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

69.8% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	No prior comparable period	Revenue: 276815 Open source
20002000-12-31	Year over year	49.2%	Revenue: 413030 Open source Revenue: 276815 Open source
20012001-12-31	Year over year	32.9%	Revenue: 548799 Open source Revenue: 413030 Open source
20022002-12-31	Year over year	141.1%	Revenue: 1323392 Open source Revenue: 548799 Open source
20032003-12-31	Year over year	69.8%	Revenue: 2246470 Open source Revenue: 1323392 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 5% 2003

Net margin 4.5% 2003

Free cash flow margin 3.2% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	-85.1%	Operating Income: -235538 Open source Revenue: 276815 Open source
20002000-12-31	Operating margin	-11%	Operating Income: -45463 Open source Revenue: 413030 Open source
20012001-12-31	Operating margin	-9.9%	Operating Income: -54090 Open source Revenue: 548799 Open source
20022002-12-31	Operating margin	1.8%	Operating Income: 23805 Open source Revenue: 1323392 Open source
20032003-12-31	Operating margin	5%	Operating Income: 113298 Open source Revenue: 2246470 Open source
19991999-12-31	Net margin	-89.9%	Net Income: -248942 Open source Revenue: 276815 Open source
20002000-12-31	Net margin	-13.3%	Net Income: -54856 Open source Revenue: 413030 Open source
20012001-12-31	Net margin	-7.8%	Net Income: -42592 Open source Revenue: 548799 Open source
20022002-12-31	Net margin	2%	Net Income: 25881 Open source Revenue: 1323392 Open source
20032003-12-31	Net margin	4.5%	Net Income: 100151 Open source Revenue: 2246470 Open source
19991999-12-31	Free cash flow margin	2.1%	Revenue: 276815 Open source Operating Cash Flow: 19433 Open source Capital Expenditure: 13631 Open source
20002000-12-31	Free cash flow margin	2%	Revenue: 413030 Open source Operating Cash Flow: 11678 Open source Capital Expenditure: 3607 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 548799 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 1323392 Open source Operating Cash Flow: 171259 Open source
20032003-12-31	Free cash flow margin	3.2%	Revenue: 2246470 Open source Operating Cash Flow: 70857 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 70.9K 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	19433	Operating Cash Flow: 19433 Open source
20002000-12-31	Operating cash flow	11678	Operating Cash Flow: 11678 Open source
20012001-12-31	Operating cash flow	Not reported	No source recorded
20022002-12-31	Operating cash flow	171259	Operating Cash Flow: 171259 Open source
20032003-12-31	Operating cash flow	70857	Operating Cash Flow: 70857 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 70.9K 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	5802	Operating Cash Flow: 19433 Open source Capital Expenditure: 13631 Open source
20002000-12-31	Free cash flow	8071	Operating Cash Flow: 11678 Open source Capital Expenditure: 3607 Open source
20012001-12-31	Free cash flow	Unavailable	No source recorded
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: 171259 Open source
20032003-12-31	Free cash flow	70857	Operating Cash Flow: 70857 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

200.9% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	Total Assets: 148960 Open source
20002000-12-31	Liabilities / assets	200.9%	Total Liabilities: 314259 Open source Total Assets: 156452 Open source
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	Total Assets: 212715 Open source
2003-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

0.44× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	0.2×	Current Assets: 129144 Open source Current Liabilities: 644762 Open source
20002000-12-31	Current assets / current liabilities	0.44×	Current Assets: 136969 Open source Current Liabilities: 313960 Open source
2001-12-31	Current assets / current liabilities	Not reported	No source recorded
2002-12-31	Current assets / current liabilities	Not reported	Current Liabilities: 198720 Open source
2003-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 248,942 Exact value Exact value: -248942 USD 1999-01-01 – 1999-12-31: -248942 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROGENESIS INC · 1999-12-31 NEUROGENESIS INC (edgar:848071) Net Income: -248942 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -248942 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#760 The citation records this snapshot. The page link may show a newer release later.	USD 19,433 Exact value Exact value: 19433 USD 1999-01-01 – 1999-12-31: 19433 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROGENESIS INC · 1999-12-31 NEUROGENESIS INC (edgar:848071) Operating Cash Flow: 19433 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 19433 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#770 The citation records this snapshot. The page link may show a newer release later.	USD 13,631 Exact value Exact value: 13631 USD 1999-01-01 – 1999-12-31: 13631 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROGENESIS INC · 1999-12-31 NEUROGENESIS INC (edgar:848071) Capital Expenditure: 13631 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13631 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#774 The citation records this snapshot. The page link may show a newer release later.	USD 5,802 Calculation and evidence 19433 − 13631 USD Exact free cash flow: 5802 USD 1999-01-01 – 1999-12-31: 19433 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 13631 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROGENESIS INC · 1999-12-31 NEUROGENESIS INC (edgar:848071) Free cash flow: 5802 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 19433 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#770 Input fundies:CapitalExpenditure: 13631 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#774 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 54,856 Exact value Exact value: -54856 USD 2000-01-01 – 2000-12-31: -54856 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROGENESIS INC · 2000-12-31 NEUROGENESIS INC (edgar:848071) Net Income: -54856 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54856 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-03-000010.txt#974 The citation records this snapshot. The page link may show a newer release later.	USD 11,678 Exact value Exact value: 11678 USD 2000-01-01 – 2000-12-31: 11678 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROGENESIS INC · 2000-12-31 NEUROGENESIS INC (edgar:848071) Operating Cash Flow: 11678 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11678 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#770 The citation records this snapshot. The page link may show a newer release later.	USD 3,607 Exact value Exact value: 3607 USD 2000-01-01 – 2000-12-31: 3607 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROGENESIS INC · 2000-12-31 NEUROGENESIS INC (edgar:848071) Capital Expenditure: 3607 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3607 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#774 The citation records this snapshot. The page link may show a newer release later.	USD 8,071 Calculation and evidence 11678 − 3607 USD Exact free cash flow: 8071 USD 2000-01-01 – 2000-12-31: 11678 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 3607 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROGENESIS INC · 2000-12-31 NEUROGENESIS INC (edgar:848071) Free cash flow: 8071 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11678 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#770 Input fundies:CapitalExpenditure: 3607 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001111324-01-500092.txt#774 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 42,592 Exact value Exact value: -42592 USD 2001-01-01 – 2001-12-31: -42592 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROGENESIS INC · 2001-12-31 NEUROGENESIS INC (edgar:848071) Net Income: -42592 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42592 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-03-000018.txt#955 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	USD 25,881 Exact value Exact value: 25881 USD 2002-01-01 – 2002-12-31: 25881 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROGENESIS INC · 2002-12-31 NEUROGENESIS INC (edgar:848071) Net Income: 25881 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 25881 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000007.txt#962 The citation records this snapshot. The page link may show a newer release later.	USD 171,259 Exact value Exact value: 171259 USD 2002-01-01 – 2002-12-31: 171259 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROGENESIS INC · 2002-12-31 NEUROGENESIS INC (edgar:848071) Operating Cash Flow: 171259 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 171259 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#312 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	USD 100,151 Exact value Exact value: 100151 USD 2003-01-01 – 2003-12-31: 100151 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Net Income: 100151 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 100151 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000007.txt#962 The citation records this snapshot. The page link may show a newer release later.	USD 70,857 Exact value Exact value: 70857 USD 2003-01-01 – 2003-12-31: 70857 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Operating Cash Flow: 70857 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 70857 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#312 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#318 The citation records this snapshot. The page link may show a newer release later.	USD 70,857 Calculation and evidence 70857 − 0 USD Exact free cash flow: 70857 USD 2003-01-01 – 2003-12-31: 70857 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEUROGENESIS INC · 2003-12-31 NEUROGENESIS INC (edgar:848071) Free cash flow: 70857 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:58Z Snapshot: 3ce6becf91c700d6acdbce98ec658b7a85ec55e5b9eb1f780dac1748481796a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/848071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 70857 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#312 Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/848071/0001170747-04-000004.txt#318 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000848071, 848071, edgar:848071

NEUROGENESIS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation